These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 313270)

  • 1. Characterization of a human mitogenic factor (MF) released by phytohemagglutinin-activated lymphocytes.
    Larsson EL; Mannervik B; Blomgren H
    Cell Immunol; 1979 May; 44(2):424-32. PubMed ID: 313270
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory factors of lymphocyte-lymphocyte interaction. II. Characterization of human mitogenic factor derived from the culture supernatant of a mouse-human hybridoma.
    Kawano M; Namba Y; Hanaoka M
    Microbiol Immunol; 1982; 26(3):253-69. PubMed ID: 6981047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of increased temperature on in vitro production of mitogenic lymphokines by human lymphocytes].
    Voĭtenok NN; Potapnev MP
    Biull Eksp Biol Med; 1982 Feb; 93(2):45-6. PubMed ID: 6978161
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cellular regulation of human lymphocyte mitogenic factor release in vitro].
    Voĭteniuk NN; Varivotskaia NV
    Biull Eksp Biol Med; 1979 Dec; 88(12):720-2. PubMed ID: 391297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and molecular properties of mitogenic factors produced by mixed lymphocyte reactions (MLC-MF) in humans and guinea pigs.
    de Weck AL; Otz U; Geczy C; Geczy AF
    Transplant Proc; 1979 Jun; 11(2):1387-9. PubMed ID: 157577
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphokine (interleukin-2) production by mitogen-stimulated human lymphocytes in small reactors.
    Bödeker BG; Lehmann J; Mühlradt PF
    Dev Biol Stand; 1981; 50():193-200. PubMed ID: 6978826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.
    Mier JW; Gallo RC
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6134-8. PubMed ID: 6969402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of a malaria mitogen.
    Greenwood BM; Oduloju AJ; Platts-Mills TA
    Trans R Soc Trop Med Hyg; 1979; 73(2):178-82. PubMed ID: 382464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of lymphocyte mitogenic factor released in vivo during a cell-mediated immune reaction in the guinea pig.
    Postlethwaite AE
    J Immunol; 1980 Nov; 125(5):1955-8. PubMed ID: 6968767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of DNA synthesis in isolated nuclei by cytoplasmic factors from spontaneously proliferating and mitogen-activated lymphoid cells.
    Gutowski JK; Cohen S
    Cell Immunol; 1983 Feb; 75(2):300-11. PubMed ID: 6831565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bestatin, a new immunomodulator, augments the release of mitogenic factors from PHA-stimulated human lymphocytes.
    Blomgren H
    Biomedicine; 1981 Dec; 34(4):188-92. PubMed ID: 6979352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a lymphokine produced by human T cells which inhibits collagen synthesis.
    Rosenbloom J; McArthur W; Malamud D; Jimenez S
    Cell Immunol; 1983 Oct; 81(1):192-8. PubMed ID: 6604586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
    Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
    J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro detection of lymphokines produced by in vivo activated lymphocytes.
    Mohler KM; Butler LD
    J Immunol Methods; 1989 Jul; 121(1):67-73. PubMed ID: 2787822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage requirement for production of the human mitogenic factor in vitro.
    Larsson EL
    Scand J Immunol; 1978; 8(5):465-8. PubMed ID: 310155
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20).
    Barak V; Treves AJ; Yanai P; Halperin M; Wasserman D; Biran S; Braun S
    Eur J Immunol; 1986 Nov; 16(11):1449-52. PubMed ID: 3490987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 production by cord blood lymphocytes stimulated with mitogen and in the mixed leukocyte culture.
    Hauser GJ; Zakuth V; Rosenberg H; Bino T; Spirer Z
    J Clin Lab Immunol; 1985 Jan; 16(1):37-40. PubMed ID: 3156997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics.
    Hübner L; Müller G; Schimpl A; Wecker E
    Immunochemistry; 1978 Jan; 15(1):33-9. PubMed ID: 75173
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity of mouse interleukins.
    Henriksen O; Alvarez VL; Barnes M; Bächtold H; Frey JR; Hansson E; Howie S; Lefkovits I; Roitsch CA; Söderberg A; Young P
    FEBS Lett; 1980 Nov; 121(1):157-60. PubMed ID: 6780374
    [No Abstract]   [Full Text] [Related]  

  • 20. Ergot alkaloid-induced cell proliferation, cytotoxicity, and lymphokine production.
    Fiserová A; Trinchieri G; Chan S; Bezouska K; Flieger M; Pospisil M
    Adv Exp Med Biol; 1995; 371A():163-6. PubMed ID: 8525898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.